50
Participants
Start Date
October 1, 2020
Primary Completion Date
April 5, 2022
Study Completion Date
April 5, 2022
QL (quadratus lumborum) block administration
Fo the QL block group, they will be receiving bilateral QL block. A total of 40ml of 0.25% bupivacaine (Marcaine) and 10ml of liposomal bupivacaine (Exparel) will be administered
Maimonides Medical Center, Brooklyn
Pedram Bral
OTHER